Showing results (251-260 of 259) with videos related to
Sort By:
Pageof 26
You have reached the last page of results.This site can display upto 259 results.
The Lancet. HIV|September 23, 2021
Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortiumLoveleen Bansi-Matharu, Andrew Phillips, Cristiana Oprea, et al.Plos Genetics|December 31, 2009
Common genetic variation and the control of HIV-1 in humansJacques Fellay, Dongliang Ge, Kevin V Shianna, et al.BMJ Open|August 6, 2021
Multicentre, randomised, open-label, phase IV-III study to evaluate the efficacy of cloxacillin plus fosfomycin versus cloxacillin alone in adult patients with methicillin-susceptible <i>Staphylococcus aureus</i> bacteraemia: study protocol for the SAFO trialSara Grillo, Guillermo Cuervo, Jordi Carratala, et al.The Lancet. HIV|April 16, 2017
Comparison of dynamic monitoring strategies based on CD4 cell counts in virally suppressed, HIV-positive individuals on combination antiretroviral therapy in high-income countries: a prospective, observational studyEllen C Caniglia, Lauren E Cain, Caroline A Sabin, et al.Proceedings of the National Academy of Sciences of the United States of America|November 11, 2015
Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus loadPaul J McLaren, Cedric Coulonges, István Bartha, et al.Statistics in Medicine|March 19, 2019
Emulating a trial of joint dynamic strategies: An application to monitoring and treatment of HIV-positive individualsEllen C Caniglia, James M Robins, Lauren E Cain, et al.Plos Pathogens|August 13, 2013
Association study of common genetic variants and HIV-1 acquisition in 6,300 infected cases and 7,200 controlsPaul J McLaren, Cédric Coulonges, Stephan Ripke, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 31, 2016
Mortality According to CD4 Count at Start of Combination Antiretroviral Therapy Among HIV-infected Patients Followed for up to 15 Years After Start of Treatment: Collaborative Cohort StudyMargaret T May, Jorg-Janne Vehreschild, Adam Trickey, et al.Nature|August 2, 2023
Africa-specific human genetic variation near CHD1L associates with HIV-1 loadPaul J McLaren, Immacolata Porreca, Gennaro Iaconis, et al.Pageof 26